{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:35:07Z","timestamp":1792154107702,"version":"4.4.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00210-026-05341-6","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T03:14:55Z","timestamp":1777346095000},"page":"14705-14717","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Repurposing metformin for choriocarcinoma: targeting the AMPK\/mTOR pathway"],"prefix":"10.1007","volume":"399","author":[{"given":"Nuha Nabeel Abdullah","family":"Filfilan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayder M.","family":"Al-kuraishy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed N.","family":"Fawzy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaber El-Saber","family":"Batiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"key":"5341_CR1","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/cpt.3639","volume":"118","author":"AS Ailabouni","year":"2025","unstructured":"Ailabouni AS, Singh DK, Thakur A et al (2025) Quantitative contributions of hepatic and renal organic cation transporters to the clinical pharmacokinetic cimetidine\u2013metformin interaction. Clin Pharmacol Ther 118:343\u2013354. https:\/\/doi.org\/10.1002\/cpt.3639","journal-title":"Clin Pharmacol Ther"},{"key":"5341_CR2","doi-asserted-by":"publisher","first-page":"200","DOI":"10.5001\/omj.2019.39","volume":"34","author":"N Al Riyami","year":"2019","unstructured":"Al Riyami N, Al Riyami M, Al Hajri AT, Al Saidi S, Salman B, Al Kalbani M (2019) Gestational trophoblastic disease at Sultan Qaboos University Hospital: prevalence, risk factors, histological features, sonographic findings, and outcomes. Oman Med J 34:200\u2013204. https:\/\/doi.org\/10.5001\/omj.2019.39","journal-title":"Oman Med J"},{"key":"5341_CR3","doi-asserted-by":"publisher","unstructured":"Alazzam M, Tidy J, Osborne R et al (2016) Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia. Cochrane Database Syst Rev 2019:. https:\/\/doi.org\/10.1002\/14651858.CD008891.pub3","DOI":"10.1002\/14651858.CD008891.pub3"},{"key":"5341_CR4","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/1471-0528.17374","volume":"130","author":"BB Albright","year":"2023","unstructured":"Albright BB, Ellett T, Knochenhauer HE et al (2023) Treatments and outcomes in high\u2010risk gestational trophoblastic neoplasia: a systematic review and meta\u2010analysis. BJOG 130:443\u2013453. https:\/\/doi.org\/10.1111\/1471-0528.17374","journal-title":"BJOG"},{"key":"5341_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0204420","volume":"13","author":"TJ Alharbi","year":"2018","unstructured":"Alharbi TJ, Tourkmani AM, Abdelhay O et al (2018) The association of metformin use with vitamin B12 deficiency and peripheral neuropathy in Saudi individuals with type 2 diabetes mellitus. PLoS One 13:e0204420. https:\/\/doi.org\/10.1371\/journal.pone.0204420","journal-title":"PLoS One"},{"key":"5341_CR6","doi-asserted-by":"publisher","DOI":"10.2144\/fsoa-2019-0053","author":"M Aljofan","year":"2019","unstructured":"Aljofan M, Riethmacher D (2019) Anticancer activity of metformin: a systematic review of the literature. Future Sci OA. https:\/\/doi.org\/10.2144\/fsoa-2019-0053","journal-title":"Future Sci OA"},{"key":"5341_CR7","doi-asserted-by":"publisher","first-page":"5355","DOI":"10.1097\/MS9.0000000000001314","volume":"85","author":"A Al-Khayal","year":"2023","unstructured":"Al-Khayal A, Noureldin Y, Alghafees M et al (2023) A decade in focus: mixed germ cell tumors with choriocarcinoma components. Ann Med Surg 85:5355\u20135358. https:\/\/doi.org\/10.1097\/MS9.0000000000001314","journal-title":"Ann Med Surg"},{"key":"5341_CR8","doi-asserted-by":"publisher","unstructured":"Alshwayyat S, Hawa MBA Al, Maraqa K et al (2025) Outcomes in gestational and non-gestational choriocarcinoma: a retrospective cohort study with nomograms and web tools. Women\u2019s Health 21:. https:\/\/doi.org\/10.1177\/17455057251344386","DOI":"10.1177\/17455057251344386"},{"key":"5341_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5402\/2012\/757913","volume":"2012","author":"A Alzamendi","year":"2012","unstructured":"Alzamendi A, Del Zotto H, Castrogiovanni D et al (2012) Oral metformin treatment prevents enhanced insulin demand and placental dysfunction in the pregnant rat fed a fructose-rich diet. ISRN Endocrinol 2012:1\u20138. https:\/\/doi.org\/10.5402\/2012\/757913","journal-title":"ISRN Endocrinol"},{"key":"5341_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.6640","author":"M Azizi","year":"2022","unstructured":"Azizi M, Akbarzade\u2010Jahromi M, Ghaffari P, Ramezani M (2022) Delayed diagnosis of intraplacental choriocarcinoma in a term healthy neonate\u2014a case report and literature review. Clin Case Rep. https:\/\/doi.org\/10.1002\/ccr3.6640","journal-title":"Clin Case Rep"},{"key":"5341_CR11","doi-asserted-by":"publisher","DOI":"10.1177\/2042018820980225","author":"C Baker","year":"2021","unstructured":"Baker C, Retzik-Stahr C, Singh V et al (2021) Should metformin remain the first-line therapy for treatment of type 2 diabetes? Ther Adv Endocrinol Metab. https:\/\/doi.org\/10.1177\/2042018820980225","journal-title":"Ther Adv Endocrinol Metab"},{"key":"5341_CR12","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.ygyno.2020.05.042","volume":"158","author":"PA Bolze","year":"2020","unstructured":"Bolze PA, Lopez J, Allias F et al (2020) Transcriptomic and immunohistochemical approaches identify HLA-G as a predictive biomarker of gestational choriocarcinoma resistance to monochemotherapy. Gynecol Oncol 158:785\u2013793. https:\/\/doi.org\/10.1016\/j.ygyno.2020.05.042","journal-title":"Gynecol Oncol"},{"key":"5341_CR13","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1055\/s-0041-1735177","volume":"43","author":"A Braga","year":"2021","unstructured":"Braga A, Elias KM, Horowitz NS, Berkowitz RS (2021) Challenges in the treatment of low-risk gestational trophoblastic neoplasia. Revista Brasileira De Ginecologia e Obstetr\u00edcia \/ RBGO Gynecology and Obstetrics 43:503\u2013506. https:\/\/doi.org\/10.1055\/s-0041-1735177","journal-title":"Revista Brasileira De Ginecologia e Obstetr\u00edcia \/ RBGO Gynecology and Obstetrics"},{"key":"5341_CR14","first-page":"267","volume":"56","author":"E Br\u0103til\u0103","year":"2015","unstructured":"Br\u0103til\u0103 E, Ionescu CA, Vl\u0103descu CT et al (2015) Gestational choriocarcinoma after term pregnancy: a case report. Rom J Morphol Embryol 56:267\u2013271","journal-title":"Rom J Morphol Embryol"},{"key":"5341_CR15","doi-asserted-by":"publisher","first-page":"198","DOI":"10.2337\/dc15-1531","volume":"39","author":"JB Buse","year":"2016","unstructured":"Buse JB, DeFronzo RA, Rosenstock J et al (2016) The primary glucose lowering effect of metformin resides in the gut, not the circulation: results from short term pharmacokinetic and 12 week dose ranging studies. Diabetes Care 39:198\u2013205. https:\/\/doi.org\/10.2337\/dc15-1531","journal-title":"Diabetes Care"},{"key":"5341_CR16","doi-asserted-by":"publisher","unstructured":"Cheng M, Ren L, Jia X et al (2024a) Understanding the action mechanisms of metformin in the gastrointestinal tract. Front Pharmacol 15:. https:\/\/doi.org\/10.3389\/fphar.2024.1347047","DOI":"10.3389\/fphar.2024.1347047"},{"key":"5341_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1347047","author":"M Cheng","year":"2024","unstructured":"Cheng M, Ren L, Jia X et al (2024b) Understanding the action mechanisms of metformin in the gastrointestinal tract. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2024.1347047","journal-title":"Front Pharmacol"},{"key":"5341_CR18","doi-asserted-by":"publisher","unstructured":"Chomanicova N, Gazova A, Adamickova A et al (2021) The role of AMPK\/mTOR signaling pathway in anticancer activity of metformin. Physiol Res 501\u2013508. https:\/\/doi.org\/10.33549\/physiolres.934618","DOI":"10.33549\/physiolres.934618"},{"key":"5341_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.gore.2020.100625","volume":"34","author":"KH Clair","year":"2020","unstructured":"Clair KH, Gallegos N, Bristow RE (2020) Successful treatment of metastatic refractory gestational choriocarcinoma with pembrolizumab: a case for immune checkpoint salvage therapy in trophoblastic tumors. Gynecol Oncol Rep 34:100625. https:\/\/doi.org\/10.1016\/j.gore.2020.100625","journal-title":"Gynecol Oncol Rep"},{"key":"5341_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/GCO.0000000000000674","volume":"33","author":"JJ Clark","year":"2021","unstructured":"Clark JJ, Slater S, Seckl MJ (2021) Treatment of gestational trophoblastic disease in the 2020s. Curr Opin Obstet Gynecol 33:7\u201312. https:\/\/doi.org\/10.1097\/GCO.0000000000000674","journal-title":"Curr Opin Obstet Gynecol"},{"key":"5341_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25031925","volume":"25","author":"Q Dang","year":"2024","unstructured":"Dang Q, Zhu Y, Zhang Y et al (2024) Nuclear binding protein 2\/Nesfatin-1 affects trophoblast cell fusion during placental development via the EGFR-PLCG1-CAMK4 pathway. Int J Mol Sci 25:1925. https:\/\/doi.org\/10.3390\/ijms25031925","journal-title":"Int J Mol Sci"},{"key":"5341_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.crwh.2025.e00772","volume":"49","author":"D Dannehl","year":"2026","unstructured":"Dannehl D, Taran F-A (2026) Choriocarcinoma: navigating risk, resistance, and remarkable curability. Case Rep Womens Health 49:e00772. https:\/\/doi.org\/10.1016\/j.crwh.2025.e00772","journal-title":"Case Rep Womens Health"},{"key":"5341_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-37247-6","volume":"9","author":"M De Santi","year":"2019","unstructured":"De Santi M, Baldelli G, Diotallevi A et al (2019) Metformin prevents cell tumorigenesis through autophagy-related cell death. Sci Rep 9:66. https:\/\/doi.org\/10.1038\/s41598-018-37247-6","journal-title":"Sci Rep"},{"key":"5341_CR24","doi-asserted-by":"publisher","unstructured":"Della Corte CM, Ciaramella V, Mauro C Di et al (2016) Metformin increases antitumor activity of MEK inhibitors through GLI1 downregulation in LKB1 positive human NSCLC cancer cells. Oncotarget 7:4265\u20134278. https:\/\/doi.org\/10.18632\/oncotarget.6559","DOI":"10.18632\/oncotarget.6559"},{"key":"5341_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004662","volume":"22","author":"A Dokras","year":"2025","unstructured":"Dokras A, Coutifaris C, Remaley AT et al (2025) Impact of combined hormonal contraceptives and metformin on metabolic syndrome in women with hyperandrogenic polycystic ovary syndrome and obesity: the COMET-PCOS randomized clinical trial. PLoS Med 22:e1004662. https:\/\/doi.org\/10.1371\/journal.pmed.1004662","journal-title":"PLoS Med"},{"key":"5341_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2026.101459","volume":"108","author":"C Espinoza","year":"2026","unstructured":"Espinoza C, Veas-Torres J, Miranda DI, Owen GI (2026) Impact of type 2 diabetes on malignancies of the female reproductive system. Mol Aspects Med 108:101459. https:\/\/doi.org\/10.1016\/j.mam.2026.101459","journal-title":"Mol Aspects Med"},{"key":"5341_CR27","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.cmet.2012.12.001","volume":"17","author":"B Faubert","year":"2013","unstructured":"Faubert B, Boily G, Izreig S et al (2013) AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in\u00a0vivo. Cell Metab 17:113\u2013124. https:\/\/doi.org\/10.1016\/j.cmet.2012.12.001","journal-title":"Cell Metab"},{"key":"5341_CR28","doi-asserted-by":"publisher","unstructured":"Francesco P, Fabiana C, Djaballah Selma A et al (2026) Choriocarcinoma: Diagnosis, treatment and management of a rare germ cell tumour. An update review. Tumori J. https:\/\/doi.org\/10.1177\/03008916251408266","DOI":"10.1177\/03008916251408266"},{"key":"5341_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-026-02662-z","author":"Y Fushimi","year":"2026","unstructured":"Fushimi Y, Kimura T, Sanada J et al (2026) Effect of metformin dose reduction versus continuation at imeglimin initiation on glycemic control in type 2 diabetes: a retrospective real-world analysis. Acta Diabetol. https:\/\/doi.org\/10.1007\/s00592-026-02662-z","journal-title":"Acta Diabetol"},{"key":"5341_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115732","volume":"215","author":"R Giordo","year":"2023","unstructured":"Giordo R, Posadino AM, Mangoni AA, Pintus G (2023) Metformin-mediated epigenetic modifications in diabetes and associated conditions: biological and clinical relevance. Biochem Pharmacol 215:115732. https:\/\/doi.org\/10.1016\/j.bcp.2023.115732","journal-title":"Biochem Pharmacol"},{"key":"5341_CR31","doi-asserted-by":"publisher","first-page":"439","DOI":"10.32074\/1591-951X-N994","volume":"117","author":"A Guerriero","year":"2025","unstructured":"Guerriero A, Alessandrini L, Santoro L et al (2025) Early gestational choriocarcinoma: report of two cases and review of the literature. Pathologica 117:439\u2013442. https:\/\/doi.org\/10.32074\/1591-951X-N994","journal-title":"Pathologica"},{"key":"5341_CR32","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3390\/antiox12030719","volume":"12","author":"JF Hebert","year":"2023","unstructured":"Hebert JF, Myatt L (2023) Metformin impacts human syncytiotrophoblast mitochondrial function from pregnancies complicated by obesity and gestational diabetes mellitus in a sexually dimorphic manner. Antioxidants 12:719. https:\/\/doi.org\/10.3390\/antiox12030719","journal-title":"Antioxidants"},{"key":"5341_CR33","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.ygyno.2021.10.003","volume":"163","author":"NS Horowitz","year":"2021","unstructured":"Horowitz NS, Eskander RN, Adelman MR, Burke W (2021) Epidemiology, diagnosis, and treatment of gestational trophoblastic disease: a Society of Gynecologic Oncology evidenced-based review and recommendation. Gynecol Oncol 163:605\u2013613. https:\/\/doi.org\/10.1016\/j.ygyno.2021.10.003","journal-title":"Gynecol Oncol"},{"key":"5341_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1382672","author":"W Huang","year":"2024","unstructured":"Huang W, Zheng Z, Bao Z et al (2024) A poor prognostic male choriocarcinoma with multiple systemic metastases: a case report and the literature review. Front Med (Lausanne). https:\/\/doi.org\/10.3389\/fmed.2024.1382672","journal-title":"Front Med (Lausanne)"},{"key":"5341_CR35","doi-asserted-by":"publisher","DOI":"10.1515\/crpm-2024-0041","author":"C Illi","year":"2025","unstructured":"Illi C, Henrich W, Hinkson L (2025) Gestational choriocarcinoma FIGO stage III, score 8 (high-risk) in 38-year-old woman four weeks postpartum. Case Rep Perinat Med. https:\/\/doi.org\/10.1515\/crpm-2024-0041","journal-title":"Case Rep Perinat Med"},{"key":"5341_CR36","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1097\/CAD.0000000000000966","volume":"31","author":"JH Jang","year":"2020","unstructured":"Jang JH, Sung E-G, Song I-H et al (2020) Metformin induces caspase-dependent and caspase-independent apoptosis in human bladder cancer T24 cells. Anticancer Drugs 31:655\u2013662. https:\/\/doi.org\/10.1097\/CAD.0000000000000966","journal-title":"Anticancer Drugs"},{"key":"5341_CR37","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.annonc.2025.06.006","volume":"36","author":"F Jiang","year":"2025","unstructured":"Jiang F, Guan CL, Jiao LZ et al (2025) Efficacy and safety of biweekly single-dose actinomycin D versus multiday methotrexate in low-risk gestational trophoblastic neoplasia: a prospective multicenter randomized trial. Ann Oncol 36:1123\u20131131. https:\/\/doi.org\/10.1016\/j.annonc.2025.06.006","journal-title":"Ann Oncol"},{"key":"5341_CR38","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/dme.12959","volume":"33","author":"F Kajbaf","year":"2016","unstructured":"Kajbaf F, Bennis Y, Hurtel\u2010Lemaire A\u2010S et al (2016) Unexpectedly long half\u2010life of metformin elimination in cases of metformin accumulation. Diabet Med 33:105\u2013110. https:\/\/doi.org\/10.1111\/dme.12959","journal-title":"Diabet Med"},{"key":"5341_CR39","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.22200","author":"E Katsanevakis","year":"2022","unstructured":"Katsanevakis E, Oatham A, Mathew D (2022) Choriocarcinoma after full-term pregnancy: a case report and review of the literature. Cureus. https:\/\/doi.org\/10.7759\/cureus.22200","journal-title":"Cureus"},{"key":"5341_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1114582","author":"CK Keerthana","year":"2023","unstructured":"Keerthana CK, Rayginia TP, Shifana SC et al (2023) The role of AMPK in cancer metabolism and its impact on the immunomodulation of the tumor microenvironment. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2023.1114582","journal-title":"Front Immunol"},{"key":"5341_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1035170","author":"L Kemin","year":"2022","unstructured":"Kemin L, Mengpei Z, Rutie Y (2022) Monotherapy for low-risk gestational trophoblastic neoplasia with score 5\u20136. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2022.1035170","journal-title":"Front Oncol"},{"key":"5341_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01262","author":"Y Kong","year":"2019","unstructured":"Kong Y, Tao G, Zong L et al (2019) Diagnosis and management of mixed gestational trophoblastic neoplasia: a study of 16 cases and a review of the literature. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2019.01262","journal-title":"Front Oncol"},{"key":"5341_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05583-9","volume":"14","author":"P Konieczny","year":"2023","unstructured":"Konieczny P, Adamus T, Su\u0142kowski M et al (2023) Impact of AMPK on cervical carcinoma progression and metastasis. Cell Death Dis 14:43. https:\/\/doi.org\/10.1038\/s41419-023-05583-9","journal-title":"Cell Death Dis"},{"key":"5341_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45647-8","volume":"15","author":"JG Lee","year":"2024","unstructured":"Lee JG, Yon J-M, Kim G et al (2024) PIBF1 regulates trophoblast syncytialization and promotes cardiovascular development. Nat Commun 15:1487. https:\/\/doi.org\/10.1038\/s41467-024-45647-8","journal-title":"Nat Commun"},{"key":"5341_CR45","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.3892\/ijmm.2017.2929","volume":"39","author":"W-D Li","year":"2017","unstructured":"Li W-D, Li N-P, Song D-D et al (2017) Metformin inhibits endothelial progenitor cell migration by decreasing matrix metalloproteinases, MMP-2 and MMP-9, via the AMPK\/mTOR\/autophagy pathway. Int J Mol Med 39:1262\u20131268. https:\/\/doi.org\/10.3892\/ijmm.2017.2929","journal-title":"Int J Mol Med"},{"key":"5341_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1523316","author":"X Liang","year":"2025","unstructured":"Liang X, Xu G, Zhang J et al (2025) Combination chemotherapy with sintilimab for treatment of a male patient with primary pulmonary choriocarcinoma: a case report and literature review. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2025.1523316","journal-title":"Front Immunol"},{"key":"5341_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2020.09.048","volume":"224","author":"LH Lin","year":"2021","unstructured":"Lin LH, Maesta I, St Laurent JD et al (2021) Distinct microRNA profiles for complete hydatidiform moles at risk of malignant progression. Am J Obstet Gynecol 224:372. https:\/\/doi.org\/10.1016\/j.ajog.2020.09.048","journal-title":"Am J Obstet Gynecol"},{"key":"5341_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118507","volume":"191","author":"H Lv","year":"2025","unstructured":"Lv H, Gong H, Zhao R et al (2025) From basics to clinics: new opportunities for metformin in tumor metabolic intervention and treatment. Biomed Pharmacother 191:118507. https:\/\/doi.org\/10.1016\/j.biopha.2025.118507","journal-title":"Biomed Pharmacother"},{"key":"5341_CR49","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.3390\/curroncol30020171","volume":"30","author":"EP Malovrh","year":"2023","unstructured":"Malovrh EP, Lukinovi\u010d N, Bujas T et al (2023) Ultra-high-risk gestational choriocarcinoma of the ovary associated with ectopic pregnancy. Curr Oncol 30:2217\u20132226. https:\/\/doi.org\/10.3390\/curroncol30020171","journal-title":"Curr Oncol"},{"key":"5341_CR50","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1055\/s-0044-1788590","volume":"35","author":"A Mandava","year":"2025","unstructured":"Mandava A, Koppula V, Kandati M et al (2025) Multimodality imaging in the diagnosis and staging of gestational choriocarcinoma. Indian J Radiol Imaging 35:148\u2013158. https:\/\/doi.org\/10.1055\/s-0044-1788590","journal-title":"Indian J Radiol Imaging"},{"key":"5341_CR51","doi-asserted-by":"publisher","DOI":"10.1515\/jbcpp-2025-0201","author":"S Misra","year":"2026","unstructured":"Misra S, Deb T, Devi S et al (2026) Metformin modulates antioxidant and anti-inflammatory biomarkers in newly diagnosed patients with type 2 diabetes mellitus: an observational study. J Basic Clin Physiol Pharmacol. https:\/\/doi.org\/10.1515\/jbcpp-2025-0201","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"5341_CR52","doi-asserted-by":"publisher","first-page":"C694","DOI":"10.1152\/ajpcell.00177.2021","volume":"321","author":"KH Moore","year":"2021","unstructured":"Moore KH, Murphy HA, Chapman H, George EM (2021) Syncytialization alters the extracellular matrix and barrier function of placental trophoblasts. Am J Physiol Cell Physiol 321:C694\u2013C703. https:\/\/doi.org\/10.1152\/ajpcell.00177.2021","journal-title":"Am J Physiol Cell Physiol"},{"key":"5341_CR53","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2016-000132","volume":"2","author":"F Morgillo","year":"2017","unstructured":"Morgillo F, Fasano M, Della Corte CM et al (2017) Results of the safety run-in part of the METAL (METformin in Advanced Lung cancer) study: a multicentre, open-label phase I\u2013II study of metformin with erlotinib in second-line therapy of patients with stage IV non-small-cell lung cancer. ESMO Open 2:e000132. https:\/\/doi.org\/10.1136\/esmoopen-2016-000132","journal-title":"ESMO Open"},{"key":"5341_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1167097","author":"SK Nashif","year":"2023","unstructured":"Nashif SK, Mahr RM, Jena S et al (2023) Metformin impairs trophoblast metabolism and differentiation in a dose-dependent manner. Front Cell Dev Biol. https:\/\/doi.org\/10.3389\/fcell.2023.1167097","journal-title":"Front Cell Dev Biol"},{"key":"5341_CR55","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.052010","author":"A Nicheperovich","year":"2025","unstructured":"Nicheperovich A, Schuster-B\u00f6ckler B, N\u00ed Leathlobhair M (2025) Gestational trophoblastic disease: understanding the molecular mechanisms of placental tumours. Dis Model Mech. https:\/\/doi.org\/10.1242\/dmm.052010","journal-title":"Dis Model Mech"},{"key":"5341_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1526709","author":"P Nie","year":"2025","unstructured":"Nie P, Wang M, Mo Y et al (2025) Metformin in gynecological disorders: pathogenic insights and therapeutic implications. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2025.1526709","journal-title":"Front Pharmacol"},{"key":"5341_CR57","doi-asserted-by":"publisher","unstructured":"Ning F, Liu Y, Li W et al (2024) Gestational trophoblastic disease: pathogenesis and concept of gestational choriocarcinoma. Front Oncol 14:. https:\/\/doi.org\/10.3389\/fonc.2024.1444658","DOI":"10.3389\/fonc.2024.1444658"},{"key":"5341_CR58","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.biochi.2025.03.002","volume":"233","author":"RS Pal","year":"2025","unstructured":"Pal RS, Jawaid T, Rahman MA et al (2025) Metformin\u2019s anticancer odyssey: revealing multifaceted mechanisms across diverse neoplastic terrains- a critical review. Biochimie 233:109\u2013121. https:\/\/doi.org\/10.1016\/j.biochi.2025.03.002","journal-title":"Biochimie"},{"key":"5341_CR59","doi-asserted-by":"publisher","unstructured":"Pi\u0105tek S, Szcz\u0119sny N, Szymusik I et al (2023) Fertility-sparing treatment in gestational choriocarcinoma: evaluating oncological and obstetrical outcomes in young patients. Med Sci Monit 29:. https:\/\/doi.org\/10.12659\/MSM.942078","DOI":"10.12659\/MSM.942078"},{"key":"5341_CR60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0098207","volume":"9","author":"EAIF Queiroz","year":"2014","unstructured":"Queiroz EAIF, Puukila S, Eichler R et al (2014) Metformin induces apoptosis and cell cycle arrest mediated by oxidative stress, AMPK and FOXO3a in MCF-7 breast cancer cells. PLoS One 9:e98207. https:\/\/doi.org\/10.1371\/journal.pone.0098207","journal-title":"PLoS One"},{"key":"5341_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17101655","volume":"17","author":"A Ruengsaen","year":"2025","unstructured":"Ruengsaen A, Sethasathien S, Tantipalakorn C et al (2025) Clinical characteristics and prognostic factors in patients with gestational trophoblastic neoplasia: a single-center study comparing ultra-high-risk and other risk groups. Cancers (Basel) 17:1655. https:\/\/doi.org\/10.3390\/cancers17101655","journal-title":"Cancers (Basel)"},{"key":"5341_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-5906-8","volume":"19","author":"P Savage","year":"2019","unstructured":"Savage P, Monk D, Hernandez Mora JR et al (2019) A case of intraplacental gestational choriocarcinoma; characterised by the methylation pattern of the early placenta and an absence of driver mutations. BMC Cancer 19:744. https:\/\/doi.org\/10.1186\/s12885-019-5906-8","journal-title":"BMC Cancer"},{"key":"5341_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2025.112424","volume":"228","author":"A Sepassi","year":"2025","unstructured":"Sepassi A, Wang J, Yankowski S et al (2025) Associations between long-term metformin use, the risk of vitamin B12 deficiency, and neuropathy: an All of Us research Program study. Diabetes Res Clin Pract 228:112424. https:\/\/doi.org\/10.1016\/j.diabres.2025.112424","journal-title":"Diabetes Res Clin Pract"},{"key":"5341_CR64","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1080\/21655979.2021.1931643","volume":"12","author":"Y Shan","year":"2021","unstructured":"Shan Y, Li Y, Han H et al (2021) Insulin reverses choriocarcinoma 5- fluorouracil resistance. Bioengineered 12:2087\u20132094. https:\/\/doi.org\/10.1080\/21655979.2021.1931643","journal-title":"Bioengineered"},{"key":"5341_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1608856","author":"J Shi","year":"2025","unstructured":"Shi J, Chen P (2025) Diagnostic pitfall in primary cervical gestational choriocarcinoma: a case report. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2025.1608856","journal-title":"Front Oncol"},{"key":"5341_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.placenta.2016.02.017","volume":"41","author":"L-J Shih","year":"2016","unstructured":"Shih L-J, Lin Y-R, Lin C-K et al (2016) Green tea (-)-epigallocatechin gallate induced growth inhibition of human placental choriocarcinoma cells. Placenta 41:1\u20139. https:\/\/doi.org\/10.1016\/j.placenta.2016.02.017","journal-title":"Placenta"},{"key":"5341_CR67","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1159\/000486317","volume":"11","author":"L Stockton","year":"2018","unstructured":"Stockton L, Green E, Kaur B, De Winton E (2018) Non-gestational choriocarcinoma with widespread metastases presenting with type 1 respiratory failure in a 39-year-old female: case report and review of the literature. Case Rep Oncol 11:151\u2013158. https:\/\/doi.org\/10.1159\/000486317","journal-title":"Case Rep Oncol"},{"key":"5341_CR68","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00795-024-00382-3","volume":"57","author":"N Takano","year":"2024","unstructured":"Takano N, Takamura M, Mizuno Y et al (2024) Genetic and histological analysis intraplacental choriocarcinoma: a case report. Med Mol Morphol 57:147\u2013154. https:\/\/doi.org\/10.1007\/s00795-024-00382-3","journal-title":"Med Mol Morphol"},{"key":"5341_CR69","doi-asserted-by":"publisher","unstructured":"Tarry-Adkins JL, Robinson IG, Reynolds RM et al (2022a) Impact of metformin treatment on human placental energy production and oxidative stress. Front Cell Dev Biol 10:. https:\/\/doi.org\/10.3389\/fcell.2022.935403","DOI":"10.3389\/fcell.2022.935403"},{"key":"5341_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.935403","author":"JL Tarry-Adkins","year":"2022","unstructured":"Tarry-Adkins JL, Robinson IG, Reynolds RM et al (2022b) Impact of metformin treatment on human placental energy production and oxidative stress. Front Cell Dev Biol. https:\/\/doi.org\/10.3389\/fcell.2022.935403","journal-title":"Front Cell Dev Biol"},{"key":"5341_CR71","doi-asserted-by":"publisher","first-page":"473","DOI":"10.22034\/APJCP.2017.18.2.473","volume":"18","author":"SX Trinh","year":"2017","unstructured":"Trinh SX, Nguyen HTB, Saimuang K et al (2017) Metformin inhibits migration and invasion of cholangiocarcinoma cells. Asian Pac J Cancer Prev 18:473\u2013477. https:\/\/doi.org\/10.22034\/APJCP.2017.18.2.473","journal-title":"Asian Pac J Cancer Prev"},{"key":"5341_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14144947","volume":"14","author":"GI Tsironikos","year":"2025","unstructured":"Tsironikos GI, Tsolaki V, Zakynthinos GE et al (2025) Metformin\u2019s overall effectiveness and combined action with lifestyle interventions in preventing type-2 diabetes mellitus in high-risk metformin-na\u00efve patients: an updated systematic review and meta-analysis of published RCTs. J Clin Med 14:4947. https:\/\/doi.org\/10.3390\/jcm14144947","journal-title":"J Clin Med"},{"key":"5341_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2022.147090","volume":"853","author":"W Tu","year":"2023","unstructured":"Tu W, Qin M, Li Y et al (2023) Metformin regulates autophagy via LGMN to inhibit choriocarcinoma. Gene 853:147090. https:\/\/doi.org\/10.1016\/j.gene.2022.147090","journal-title":"Gene"},{"key":"5341_CR74","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1101\/gad.339895.120","volume":"34","author":"JL Van Nostrand","year":"2020","unstructured":"Van Nostrand JL, Hellberg K, Luo E-C et al (2020) AMPK regulation of Raptor and TSC2 mediate metformin effects on transcriptional control of anabolism and inflammation. Genes Dev 34:1330\u20131344. https:\/\/doi.org\/10.1101\/gad.339895.120","journal-title":"Genes Dev"},{"key":"5341_CR75","doi-asserted-by":"publisher","unstructured":"Vargas-Hernandez VM, Machuca-Hernandez VF, Victor Manuel V-A et al (2021) Non-gestational primary choriocarcinoma of the ovary presentation of a clinical case. J Gynecol Res Obstet 050\u2013054. https:\/\/doi.org\/10.17352\/jgro.000105","DOI":"10.17352\/jgro.000105"},{"key":"5341_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00294","author":"G Vial","year":"2019","unstructured":"Vial G, Detaille D, Guigas B (2019) Role of mitochondria in the mechanism(s) of action of metformin. Front Endocrinol (Lausanne). https:\/\/doi.org\/10.3389\/fendo.2019.00294","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5341_CR77","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/4071111","author":"X Wang","year":"2022","unstructured":"Wang X, Tang J, Shen C et al (2022) Research progress of population pharmacokinetic of metformin. Biomed Res Int. https:\/\/doi.org\/10.1155\/2022\/4071111","journal-title":"Biomed Res Int"},{"key":"5341_CR78","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.4239\/wjd.v14.i10.1532","volume":"14","author":"Y Wang","year":"2023","unstructured":"Wang Y, Song M, Qi B-R (2023) Effects of insulin aspart and metformin on gestational diabetes mellitus and inflammatory markers. World J Diabetes 14:1532\u20131540. https:\/\/doi.org\/10.4239\/wjd.v14.i10.1532","journal-title":"World J Diabetes"},{"key":"5341_CR79","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1396031","author":"Y Wang","year":"2024","unstructured":"Wang Y, Jia X, Cong B (2024) Advances in the mechanism of metformin with wide-ranging effects on regulation of the intestinal microbiota. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2024.1396031","journal-title":"Front Microbiol"},{"key":"5341_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.gore.2022.100955","volume":"40","author":"AJ Wong","year":"2022","unstructured":"Wong AJ, Finch L, Pearson JM et al (2022) Retreatment of chemotherapy-resistant metastatic choriocarcinoma with immunotherapy. Gynecol Oncol Rep 40:100955. https:\/\/doi.org\/10.1016\/j.gore.2022.100955","journal-title":"Gynecol Oncol Rep"},{"key":"5341_CR81","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s11010-022-04502-4","volume":"478","author":"X Wu","year":"2023","unstructured":"Wu X, Xu W-W, Huan X et al (2023) Mechanisms of cancer cell killing by metformin: a review on different cell death pathways. Mol Cell Biochem 478:197\u2013214. https:\/\/doi.org\/10.1007\/s11010-022-04502-4","journal-title":"Mol Cell Biochem"},{"key":"5341_CR82","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ejphar.2018.04.027","volume":"830","author":"C Xia","year":"2018","unstructured":"Xia C, Liang S, He Z et al (2018) Metformin, a first-line drug for type 2 diabetes mellitus, disrupts the MALAT1\/miR-142-3p sponge to decrease invasion and migration in cervical cancer cells. Eur J Pharmacol 830:59\u201367. https:\/\/doi.org\/10.1016\/j.ejphar.2018.04.027","journal-title":"Eur J Pharmacol"},{"key":"5341_CR83","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/S1525-1578(10)60528-4","volume":"6","author":"W-C Xue","year":"2004","unstructured":"Xue W-C, Chan KYK, Feng H-C et al (2004) Promoter hypermethylation of multiple genes in hydatidiform mole and choriocarcinoma. J Mol Diagn 6:326\u2013334. https:\/\/doi.org\/10.1016\/S1525-1578(10)60528-4","journal-title":"J Mol Diagn"},{"key":"5341_CR84","doi-asserted-by":"publisher","first-page":"8845","DOI":"10.1097\/MS9.0000000000003872","volume":"87","author":"DK Yadav","year":"2025","unstructured":"Yadav DK, Ghayour U, Acharya B et al (2025) Post-term gestational choriocarcinoma presenting with hemorrhagic brain and bilateral renal metastases: a rare case report. Ann Med Surg 87:8845\u20138850. https:\/\/doi.org\/10.1097\/MS9.0000000000003872","journal-title":"Ann Med Surg"},{"key":"5341_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2010\/364508","volume":"2010","author":"KL Yap","year":"2010","unstructured":"Yap KL, Hafez MJ, Mao T-L et al (2010) Lack of a Y-chromosomal complement in the majority of gestational trophoblastic neoplasms. J Oncol 2010:1\u20136. https:\/\/doi.org\/10.1155\/2010\/364508","journal-title":"J Oncol"},{"key":"5341_CR86","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.100377","author":"TMH Yeung","year":"2025","unstructured":"Yeung TMH, O RY, Yuen K-W, Tam S (2025) A histological conundrum with a distinctive biochemical marker: a case report of primary pulmonary choriocarcinoma. Cureus. https:\/\/doi.org\/10.7759\/cureus.100377","journal-title":"Cureus"},{"key":"5341_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.175177","volume":"931","author":"B Yoval-S\u00e1nchez","year":"2022","unstructured":"Yoval-S\u00e1nchez B, Ansari F, Lange D, Galkin A (2022) Effect of metformin on intact mitochondria from liver and brain: concept revisited. Eur J Pharmacol 931:175177. https:\/\/doi.org\/10.1016\/j.ejphar.2022.175177","journal-title":"Eur J Pharmacol"},{"key":"5341_CR88","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13256-017-1290-5","volume":"11","author":"W Zhang","year":"2017","unstructured":"Zhang W, Liu B, Wu J, Sun B (2017) Hemoptysis as primary manifestation in three women with choriocarcinoma with pulmonary metastasis: a case series. J Med Case Rep 11:110. https:\/\/doi.org\/10.1186\/s13256-017-1290-5","journal-title":"J Med Case Rep"},{"key":"5341_CR89","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02493-4","volume":"10","author":"H Zhang","year":"2025","unstructured":"Zhang H, Xiao X, Pan Z, Dokudovskaya S (2025) mTOR signaling networks: mechanistic insights and translational frontiers in disease therapeutics. Signal Transduct Target Ther 10:428. https:\/\/doi.org\/10.1038\/s41392-025-02493-4","journal-title":"Signal Transduct Target Ther"},{"key":"5341_CR90","doi-asserted-by":"publisher","DOI":"10.1186\/s41065-025-00542-0","volume":"162","author":"F Zhao","year":"2025","unstructured":"Zhao F, Liu X, Qin H (2025) HOXA13 promotes high glucose-induced trophoblast cell growth and migration during gestational diabetes by regulating the smad2 pathway. Hereditas 162:176. https:\/\/doi.org\/10.1186\/s41065-025-00542-0","journal-title":"Hereditas"},{"key":"5341_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.101945","volume":"44","author":"L Zhu","year":"2024","unstructured":"Zhu L, Yang K, Ren Z et al (2024) Metformin as anticancer agent and adjuvant in cancer combination therapy: current progress and future prospect. Transl Oncol 44:101945. https:\/\/doi.org\/10.1016\/j.tranon.2024.101945","journal-title":"Transl Oncol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05341-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05341-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05341-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T03:00:39Z","timestamp":1784775639000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05341-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":91,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["5341"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05341-6","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"17 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}}]}}